With the historic achievement, two out of the five Cuban vaccine candidates, Soberana 02 with 91.2% and Abdala with 92.28% efficacy, are among the top 5 most effective anti-COVID-19 vaccines worldwide
Amid growing accusations of vaccine hoarding by global north countries and patents blocking vaccine production, researcher and filmmaker Beth Geglia writes about the importance of supporting Cuba’s vaccines which will be available to all
Patents on vaccines and on new technologies against COVID-19 are the ball and chain in the race out of the global pandemic tunnel. Our lives are worth more than the profits of big pharmaceutical companies.
In this episode of Around the World in 8 Minutes, we look at the struggle of Mumia Abu-Jamal for his rights and health, the development of various vaccine candidates in Cuba and the global mobilizations and preparations ahead of International Women’s Day
In this final and decisive phase of trials, the objective is to evaluate the efficacy, safety and immunogenicity of Soberana 02. If the vaccine produces fruitful results, Cuba will become the first country in the Latin American and the Caribbean region to develop its own vaccine
Cuba is the only country in the Latin American and the Caribbean region that is working to develop its own vaccines against COVID-19. The country has four vaccine candidates. Two of them, Soberana 02 of the Finlay Vaccine Institute (IFV) and Abdala of the Center for Genetic Engineering and Biotechnology (CIGB), will begin the third phase of clinical trials in March